Anti-JAM-A, Domain 1 (Junctional Adhesion Molecule A, Junctional Adhesion Molecule 1, JAM-1, Platele

Anti-JAM-A, Domain 1 (Junctional Adhesion Molecule A, Junctional Adhesion Molecule 1, JAM-1, Platele
Artikelnummer Größe Datenblatt Manual SDB Lieferzeit Menge Preis
J8009-05B.100 100 µg - -

3 - 19 Werktage*

1.326,00 €
 
Junction adhesion molecule (JAM)-A (also known as JAM, JAM-1 or F11R). Together with JAM-C... mehr
Produktinformationen "Anti-JAM-A, Domain 1 (Junctional Adhesion Molecule A, Junctional Adhesion Molecule 1, JAM-1, Platele"
Junction adhesion molecule (JAM)-A (also known as JAM, JAM-1 or F11R). Together with JAM-C (JAM-2) and JAM-B (VE-JAM or JAM-3), JAM-A belongs to a family of adhesion proteins with a V-C2 immunoglobulin domain organization. JAMs are important for a variety of cellular processes, including tight junction assembly, leukocyte transmigration, platelet activation, angiogenesis and virus binding. JAM-A is expressed by endothelial and epithelial cells, platelets, neutrophils, monocytes, lymphocytes and erythrocytes. Like all other JAMs, JAM-A play an important role in tight junctions where it is involved in cell-to-cell adhesion through homophilic interaction. It codistributes with other tight junction components as ZO-1, 7H6 antigen, cingulin and occludin. JAM-A also plays an important role in leukocyte transmigration. Leukocyte transmigration can be blocked by antibodies and by soluble JAM-A/Fc fusion proteins. Homophilic JAM-A interactions between leukocytes and the endothelium but also heterophilic interactions of JAM-A with the b2-integrin leukocyte function-associated antigen-1 (LFA-1) are considered to actively guide leukocytes during transmigration. Several studies imply a role of JAM-A in the initiation of atherosclerosis, since JAM-A is upregulated on early atherosclerotic endothelium and adhesion of activated platelets on activated endothelium is mediated by homophilic interactions of JAM- A. Applications: Suitable for use in Flow Cytometry, ELISA, Western Blot and Immunohistochemistry. Other applications not tested. Recommended Dilution: Immunohistochemistry: Paraffin, Flow Cytometry: 1:50, Western Blot: 1:50, Optimal dilutions to be determined by the researcher. Storage and Stability: May be stored at 4°C for short-term only. Aliquot to avoid repeated freezing and thawing. Store at -20°C. Aliquots are stable for at least 12 months. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap.
Schlagworte: Anti-JAM1, Anti-F11R, Anti-JAM-A, Anti-JAM-1, Anti-CD321, Anti-PAM-1, Anti-Platelet F11 receptor, Anti-Platelet adhesion molecule 1, Anti-Junctional adhesion molecule 1, Anti-Junctional adhesion molecule A
Hersteller: United States Biological
Hersteller-Nr: J8009-05B

Eigenschaften

Anwendung: ELISA, FC, IHC, WB
Antikörper-Typ: Polyclonal
Konjugat: No
Wirt: Rabbit
Spezies-Reaktivität: human
Immunogen: Extracellular domain from full-length human JAM-A.
Format: Affinity Purified

Handhabung & Sicherheit

Lagerung: -20°C
Versand: +4°C (International: +4°C)
Achtung
Nur für Forschungszwecke und Laboruntersuchungen: Nicht für die Anwendung im oder am Menschen!
Hier kriegen Sie ein Zertifikat
oder , um Analysenzertifikate anzufordern.
Bewertungen lesen, schreiben und diskutieren... mehr
Kundenbewertungen für "Anti-JAM-A, Domain 1 (Junctional Adhesion Molecule A, Junctional Adhesion Molecule 1, JAM-1, Platele"
Bewertung schreiben
oder , um eine Produktbewertung abzugeben.
Zuletzt angesehen